Leadership change ahead as Medicvent’s CEO transitions within Sdiptech
Umeå-based Medicvent is seeking a new CEO as Erik Lindström transitions to a new role within the parent group, Sdiptech.
News
Mucocort receives additional patent approval for its innovative patch technology
Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC).
“This approval is a significant step forward in our global growth strategy”, states Jean Lycke, Project Manager at Mucocort AB.
Umeå targets BIO-Europe: “Confident in our competitive edge in life science”
The city of Umeå is actively seeking life science companies interested in setting up operations in the region. Partnering with Umeå Biotech Incubator, the municipality sends a delegation to BIO-Europe – Europe’s largest life science conference – to forge new connections and promote Umeå’s strengths as a life science hub.
Plastic-free fertilizers from Swedish startup could boost sustainable sunflower production
The European sunflower market is facing challenges and seeking new solutions. Cropcision, a Swedish startup, has the potential to contribute to this evolving landscape. Their plastic-free precision fertilizers will be tested in a sunflower trial, supported by EIT Food, in Spain in 2025.
Experienced life science leader joins Diamyd Medical in Umeå
Sofia Mayans, who transitioned from her research to co-founding the award-winning company InfiCure Bio, is taking on a new role as Director of Business Development at Diamyd Medical in Umeå.
“With our in-house expertise and the new production facility coming online, Diamyd Medical has significant business opportunities ahead,” she says.
QureTech Bio secures major investment from Kempestiftelserna
QureTech Bio has received a substantial investment from Kempestiftelserna. A total of SEK 14 million is invested in the company by Kempestiftelserna along with the company’s largest shareholder, Nascent Invest.
Experienced CEO appointed new Chairman of Umeå Biotech Incubator
Urban Eriksson has been appointed as the new Chairman of the board for Umeå Biotech Incubator.
Umeå Biotech Incubator draws major interest ahead of NLS Days
Two business coaches from Umeå Biotech Incubator will head to the Nordic Life Science Days in Malmö on September 18-19. Their schedule is already packed with 22 pre-arranged meetings with a range of investors and potential partners for UBI’s 17 ongoing cases.
“We’ve lined up meetings with a mix of new and established contacts, both from Sweden and internationally,” say Pia Keyser and Tobias Tovedal.
Global push for medical vest that aims to enable cancer treatment for children
For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility. Umeå based Nil Medical has developed an ergonomic medical vest that conceals fluids, pumps, and tubing within the garment, allowing for unrestricted play and movement.
A national quality-of-life study is underway, in collaboration with Swedish healthcare, and Nil Medical aims to introduce the vest to the international market.
AlexoTech achieves record turnover and sees significant growth potential
Swedish biotech company AlexoTech set a new turnover record in 2023 and predicts another strong performance this year. Citing Agrisera as a local role model, CEO and founder Anders Olofsson believes there are plenty of opportunities for Umeå based AlexoTech to expand.
QureTech Bio appoints new CEO: “Strive to bring our substances to clinical trials”
Umeå based QureTech Bio, a biotechnology company developing novel antibiotics and anti-infectives, has appointed Markus Thor as the new Chief Executive Officer.
“Along with the team, I will strive to bring our substances to clinical trials”, he states.
Interview: Boreal Orchards contributes to solutions for new EU legislation
On June 17th, Boreal Orchards delivered their first batch of moss primer to Kiruna as part of the re:moss project. That same day, the EU Council adopted the Nature Restoration Law, the first comprehensive, continent-wide legislation of its kind. The law sets binding targets and obligations for EU member states to rehabilitate at least 20 percent of the EU’s land and sea areas by 2030 and all degraded ecosystems by 2050.
QureTech Bio appoints new Chairman of the Board and new Board Member
QureTech Bio AB, a biotech company that develops novel antibiotics, has announced the appointment of Lennart Hansson as its new Chairman of the Board. Hansson succeeds Sven Bergström, who is stepping down after a successful tenure leading the company’s strategic direction.
New UBI Case Aims to Revolutionize Treatment of Cryptosporidiosis
Cryptosporidiosis is one of the biggest threats to newborn calves in the global agricultural industry. It is also responsible for hundreds of thousands of human deaths in developing countries each year.
There is currently no effective treatment for the disease, but a new case at UBI is set to change that. Professor Christian Hedberg is developing a new drug with the potential to revolutionize the treatment of cryptosporidiosis worldwide.
HiloProbe secures 3 SEK Million in funding for sales initiation
Umeå based HiloProbe has raised an additional SEK 3 Million in funding from existing owners. This capital injection is a step towards achieving the next goal.
SEK 22 million in EU funding elevates the Life Science sector in Umeå
Umeå is strengthening its position as a life science hub thanks to two regional development projects receiving around €1.8 million (22 SEK million) in EU support. These projects aim to boost innovation, collaboration, and industry growth.
“This presents an opportunity to further elevate Umeå’s standing as a life science leader,” emphasizes Peter Jacobsson, Operations Coordinator at Umeå Biotech Incubator (UBI).
Founders of Xerum win Umeå University and Nordea’s Utilisation Award.
Mattias Forsell, Johan Normark and Julia Wigren Byström, the founders of the UBI Alumni Xerum AB, have been awarded Umeå University’s and Nordea’s Innovation Prize for utilisation 2024. This is for the successful COVID-19 research conducted by a clinician, a preclinical researcher, and a biomedical analyst.
MetaCurUm aims to raise SEK 100 Million – following founder’s prestigious Award
Maréne Landström, a professor of pathology at Umeå University, was named Sweden’s Cancer Researcher of the Year for 2024. Her groundbreaking research is currently being developed into a cancer treatment by the company MetaCurUm Biotech AB, which is gearing up to raise new capital for its next phase.
“MetaCurUm is aiming to secure around 100 million SEK, with substantial interest already shown by institutional investors in Sweden and Europe”, says, CEO Maarten de Château.
Mucocort initiates clinical trial of innovative patch for aphthous stomatitis
Mucocort AB has received approval from the Swedish Medical Products Agency and the Ethics Review Board to commence a clinical trial of an intraoral patch (M045A) for the treatment of aphthous stomatitis, a condition affecting approximately 2 percent of the population and causing frequent mouth ulcers with significant pain for affected patients.
“We are pleased to soon be ready to welcome our first patient to the trial,” says Jean Lycke, project manager for Mucocort AB.
SpinChem joins trailblazing alliance: “We can make a difference in the world”
SpinChem joins the Enzyme Technology Alliance – a group of six trailblazing European companies, collaborating to bring competitive solutions for the biotech industry to market at scale.
“In the Alliance, we can tackle complex challenges and offer solutions previously unimaginable”, says Emil Byström, CEO of SpinChem.